TITLE

Chemical Efficiency Fragments

AUTHOR(S)
May, Mike
PUB. DATE
August 2007
SOURCE
Drug Discovery & Development;Aug2007, Vol. 10 Issue 8, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers world news briefs related to fragmentation in pharmaceutical firms. Evotec AG announces the development of its Innovation Center for Fragmented-Based Drug Discovery with EVOlution screening platform. A partnership is made between Bayer Healthcare AG and Prosteros Biostructures GmbH in investigating the fragments crystal structures to increase drug discovery. ChemBridge Corp., launches its fragment library consisting of 12,000 compounds which smaller than 300 daltons. INSET: Searching and Stitching Software.
ACCESSION #
26073234

 

Related Articles

  • Halving Treatment Time. Breitstein, Jonna; N. T. M. // Pharmaceutical Executive;Nov2005, Vol. 25 Issue 11, p24 

    Reports on the collaboration between Bayer HealthCare AG and the Global Alliance for TB Drug Development. Significance of the collaboration for the improvement in the treatment of tuberculosis; Terms under the deal; Importance of the partnership to the pharmaceutical industry.

  • Bayer Divests Stake in Millennium Pharma.  // Chemical Market Reporter;11/3/2003, Vol. 264 Issue 15, p2 

    Reports on the end in the research collaboration between Bayer Healthcare AG and Millennium Pharmaceuticals Inc. Sale of the shares of Bayer in the biopharmaceutical firm; Aim of Bayer to reduce its net debt; Benefits of the sale for the company.

  • CLINIC ROUNDUP.  // BioWorld Today;5/20/2008, Vol. 19 Issue 98, p4 

    This section offers news briefs on the pharmaceutical industry in 2008. Bayer HealthCare AG and Nektar Therapeutics Inc of San Carlos, California have developed a drug-device combination called Amikacin Inhale which can treat pneumonia. Epeius Biotechnologies Corp. reported positive study...

  • Other News To Note.  // BioWorld Today;2/16/2011, Vol. 22 Issue 32, p2 

    This section offers news briefs on the biotechnology industry. The U.S. Food and Drug Administration has determined that the polysorbate 80-free formulation of docetaxel from Adventrx Pharmaceuticals Inc. could not be approved due to findings from the bioequivalence study. Aeolus Pharmaceuticals...

  • Bayer, OncoMed In Clinical Pact.  // Contract Pharma;May2011, Vol. 13 Issue 4, p104 

    The article offers news briefs related to collaborations within the pharmaceutical industry. OncoMed Pharmaceuticals and Bayer HealthCare expanded their collaboration for the clinical supplies of a second Wnt inhibitor. Merck & Co. and Sun Pharmaceutical Industries have entered a joint venture...

  • Regeneron, Bayer Start Phase III With VEGF Trap-Eye In Wet AMD. Morrison, Trista // BioWorld Today;8/6/2007, Vol. 18 Issue 151, p1 

    The article reports on the pivotal procedure launched by Regeneron Pharmaceuticals Inc. and partner Bayer HealthCare AG for VEGF Trap-Eye with a Phase III trial comparing the drug to Lucentis (ranibizumab, Genentech Inc.) in wet age-related macular degeneration (wet AMD). The study is designed...

  • Compugen Rockets on $540M Bayer Immunotherapy Alliance. Boggs, Jennifer // BioWorld International;8/7/2013, Vol. 18 Issue 32, p1 

    The article reports on the 44.5 percent increase in the share price of Compugen Ltd., a drug discovery company, following news of a possible 540-million-dollar deal with pharmaceutical company Bayer Healthcare to develop cancer immunotherapy drugs. Compugen began operating in the 1990s as a...

  • 13 BAYER HEALTHCARE.  // Contract Pharma;Jul/Aug2011, Vol. 13 Issue 6, p94 

    The article reports on the performance of Leverkusen, Germany-based Bayer Healthcare AG in 2010 and its prospects for growth in 2011.

  • Evotec Gets $15M Up Front In Bayer Endometriosis Pact. Sheridan, Cormac // BioWorld International;10/3/2012, Vol. 17 Issue 40, p1 

    The article announces that Evotec, developer of small molecule drugs, is to receive a total of 12 million Euros up front and 580 million more through a drug discovery alliance with pharmaceutical company Bayer Pharma AG. The drug discovery between the two companies focuses on endometriosis. It...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics